- Home
- PLRZ vs EQS Comparison
PLRZ vs EQS Comparison
Compare PLRZ & EQS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLRZ
- EQS
- Stock Information
- Founded
- PLRZ 2005
- EQS 1991
- Country
- PLRZ Israel
- EQS United States
- Employees
- PLRZ N/A
- EQS N/A
- Industry
- PLRZ
- EQS Finance Companies
- Sector
- PLRZ
- EQS Finance
- Exchange
- PLRZ NYSE
- EQS Nasdaq
- Market Cap
- PLRZ 14.7M
- EQS 13.9M
- IPO Year
- PLRZ 2024
- EQS N/A
- Fundamental
- Price
- PLRZ $0.33
- EQS $1.00
- Analyst Decision
- PLRZ
- EQS
- Analyst Count
- PLRZ 0
- EQS 0
- Target Price
- PLRZ N/A
- EQS N/A
- AVG Volume (30 Days)
- PLRZ 290.7K
- EQS 4.5K
- Earning Date
- PLRZ 02-15-2025
- EQS 01-01-0001
- Dividend Yield
- PLRZ N/A
- EQS N/A
- EPS Growth
- PLRZ N/A
- EQS N/A
- EPS
- PLRZ N/A
- EQS N/A
- Revenue
- PLRZ N/A
- EQS $1,274,000.00
- Revenue This Year
- PLRZ N/A
- EQS N/A
- Revenue Next Year
- PLRZ N/A
- EQS N/A
- P/E Ratio
- PLRZ N/A
- EQS N/A
- Revenue Growth
- PLRZ N/A
- EQS 411.65
- 52 Week Low
- PLRZ $0.28
- EQS $0.87
- 52 Week High
- PLRZ $4.80
- EQS $1.53
- Technical
- Relative Strength Index (RSI)
- PLRZ N/A
- EQS 45.90
- Support Level
- PLRZ N/A
- EQS $0.93
- Resistance Level
- PLRZ N/A
- EQS $1.06
- Average True Range (ATR)
- PLRZ 0.00
- EQS 0.05
- MACD
- PLRZ 0.00
- EQS 0.01
- Stochastic Oscillator
- PLRZ 0.00
- EQS 68.42
About PLRZ POLYRIZON LTD
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. Its technology platforms are Capture & Contain and Trap & Target.
About EQS Equus Total Return Inc.
Equus Total Return Inc is a United States-based closed-end management investment company. It invest primarily in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts and recapitalizations of existing businesses or special situations and achieve capital appreciation by making investments in equity and equity-oriented securities issued by privately-owned companies or smaller public companies in transactions.